Literature DB >> 7567473

Relative exon affinities and suboptimal splice site signals lead to non-equivalence of two cassette exons.

A Andreadis1, J A Broderick, K S Kosik.   

Abstract

Tau is a microtubule-associated protein whose transcript undergoes complex regulated splicing in the mammalian nervous system. Exons 2 and 3 of the gene are alternatively spliced cassettes in which exon 3 never appears independently of exon 2. Expression of tau minigene constructs in cells indicate that exon 2 resembles a constitutive exon, while a suboptimal branch point connected to exon 3 inhibits inclusion of exon 3 in the mRNA. Splicing of the two tau exons is controlled by their relative affinities for each other versus the affinities of their flanking exons for them.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7567473      PMCID: PMC307241          DOI: 10.1093/nar/23.17.3585

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  50 in total

1.  Structure and novel exons of the human tau gene.

Authors:  A Andreadis; W M Brown; K S Kosik
Journal:  Biochemistry       Date:  1992-11-03       Impact factor: 3.162

2.  Effect of 5' splice site mutations on splicing of the preceding intron.

Authors:  M Talerico; S M Berget
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

3.  Selection of splice sites in pre-mRNAs with short internal exons.

Authors:  Z Dominski; R Kole
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

4.  Developmentally regulated expression of specific tau sequences.

Authors:  K S Kosik; L D Orecchio; S Bakalis; R L Neve
Journal:  Neuron       Date:  1989-04       Impact factor: 17.173

Review 5.  Generation of protein isoform diversity by alternative splicing: mechanistic and biological implications.

Authors:  A Andreadis; M E Gallego; B Nadal-Ginard
Journal:  Annu Rev Cell Biol       Date:  1987

6.  Scanning and competition between AGs are involved in 3' splice site selection in mammalian introns.

Authors:  C W Smith; T T Chu; B Nadal-Ginard
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

7.  A new cationic liposome reagent mediating nearly quantitative transfection of animal cells.

Authors:  J K Rose; L Buonocore; M A Whitt
Journal:  Biotechniques       Date:  1991-04       Impact factor: 1.993

8.  The role of exon sequences in splice site selection.

Authors:  A Watakabe; K Tanaka; Y Shimura
Journal:  Genes Dev       Date:  1993-03       Impact factor: 11.361

9.  Heterogeneity of tau proteins in Alzheimer's disease. Evidence for increased expression of an isoform and preferential distribution of a phosphorylated isoform in neurites.

Authors:  W K Liu; D W Dickson; S H Yen
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

10.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

View more
  14 in total

Review 1.  Tau in neurodegenerative diseases: tau phosphorylation and assembly.

Authors:  J Avila; M Pérez; F Lim; A Gómez-Ramos; F Hernández; J J Lucas
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

2.  Tau isoforms expression in transgenic mouse model of amyotrophic lateral sclerosis.

Authors:  Ewa Usarek; Magdalena Kuźma-Kozakiewicz; Birgit Schwalenstöcker; Beata Kaźmierczak; Christoph Münch; Albert C Ludolph; Anna Barańczyk-Kuźma
Journal:  Neurochem Res       Date:  2006-05-23       Impact factor: 3.996

Review 3.  Gene-environment interplay in neurogenesis and neurodegeneration.

Authors:  Tomás Palomo; Trevor Archer; Richard J Beninger; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 4.  The roles of intrinsic disorder-based liquid-liquid phase transitions in the "Dr. Jekyll-Mr. Hyde" behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.

Authors:  Vladimir N Uversky
Journal:  Autophagy       Date:  2017-12-17       Impact factor: 16.016

5.  Potential contribution of exosomes to the prion-like propagation of lesions in Alzheimer's disease.

Authors:  Valérie Vingtdeux; Nicolas Sergeant; Luc Buée
Journal:  Front Physiol       Date:  2012-07-05       Impact factor: 4.566

6.  Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT.

Authors:  Teresa Sposito; Elisavet Preza; Colin J Mahoney; Núria Setó-Salvia; Natalie S Ryan; Huw R Morris; Charles Arber; Michael J Devine; Henry Houlden; Thomas T Warner; Trevor J Bushell; Michele Zagnoni; Tilo Kunath; Frederick J Livesey; Nick C Fox; Martin N Rossor; John Hardy; Selina Wray
Journal:  Hum Mol Genet       Date:  2015-07-01       Impact factor: 6.150

7.  Evidence for disulfide bonds in SR Protein Kinase 1 (SRPK1) that are required for activity and nuclear localization.

Authors:  Maria Koutroumani; Georgios E Papadopoulos; Metaxia Vlassi; Eleni Nikolakaki; Thomas Giannakouros
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

8.  The involvement of cholinergic neurons in the spreading of tau pathology.

Authors:  Diana Simón; Félix Hernández; Jesús Avila
Journal:  Front Neurol       Date:  2013-06-17       Impact factor: 4.003

9.  Tau exon 10 alternative splicing and tauopathies.

Authors:  Fei Liu; Cheng-Xin Gong
Journal:  Mol Neurodegener       Date:  2008-07-10       Impact factor: 14.195

10.  Ketamine induces tau hyperphosphorylation at serine 404 in the hippocampus of neonatal rats.

Authors:  Haiyan Jin; Zhiyong Hu; Mengjie Dong; Yidong Wu; Zhirui Zhu; Lili Xu
Journal:  Neural Regen Res       Date:  2013-06-15       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.